ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 938,21
-0,64%
Dow Jones
40 813,57
-1,30%
DAX
22 567,14
-0,44%
Brent Oil
70,085
0,23%
Bitcoin
81 899,43
1,06%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ

  6. Allogene Therapeutics Inc (ALLO) Cours

Allogene Therapeutics Inc

Allogene Therapeutics Inc (ALLO)

NASDAQ
1,89
-0,17
(-8,25%)
Fermé 14 Mars 9:00PM
Retardé de 15 minutes
1,90
0,01
(0,53%)
Après les heures de négociation: 12:52AM
Retardé de 15 minutes

Votre Hub pour des idées et discussions en direct en temps réel

Premium

Statistiques et détails clés

Dernier
1,90
Prix Achat
1,90
Prix Vente
1,95
Volume échangé
2 008 360
1,84 Fourchette du Jour 2,09
1,32 Plage de 52 semaines 5,11
Cap du marché
398,377M
Clôture Veille
2,06
Ouverture
2,04
Dernière Transaction
141
@
1.9
(formt)
Dernière heure de transaction
Volume financier
US$ 3 854 858
VWAP
1,9194
Volume moyen (3 m)
5 575 815
Actions en circulation
209 672 091
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-1,20
Bénéfice par action (BPA)
-1,56
Chiffre d'affairess
95k
Bénéfice net
-327,27M

À propos de Allogene Therapeutics Inc

Allogene Therapeutics Inc is a United States-based clinical stage immuno-oncology company. It is mainly engaged in the development and commercialization of genetically engineered allogeneic T cell therapies for the treatment of cancer. The company is involved in developing a pipeline of multiple all... Allogene Therapeutics Inc is a United States-based clinical stage immuno-oncology company. It is mainly engaged in the development and commercialization of genetically engineered allogeneic T cell therapies for the treatment of cancer. The company is involved in developing a pipeline of multiple allogeneic T cell product candidates utilizing validated gene editing and advanced proprietary cell manufacturing technologies. Its pipeline includes UCART19 which is developed for the treatment of relapsed or refractory acute lymphoblastic leukemia (ALL), as well as several preclinical allogeneic CAR T therapies. Show more

Secteur
Biological Pds,ex Diagnstics
Industrie
Biological Pds,ex Diagnstics
Site Web
www.allogene.com
Siège social
Wilmington, Delaware, USA
Fondé
-
Allogene Therapeutics Inc est coté dans le secteur Biological Pds,ex Diagnstics de la NASDAQ avec le ticker ALLO. Le dernier cours de clôture d'Allogene Therapeutics était de US$2,06. Au cours de la dernière année, les actions de Allogene Therapeutics ont été négociées dans une fourchette de prix de US$ 1,32 à US$ 5,11.

Allogene Therapeutics compte actuellement 209 672 091 actions en circulation. La capitalisation boursière d'Allogene Therapeutics est de US$431,92 million. Allogene Therapeutics a un ratio cours/bénéfice (ratio PE) de -1.20.

ALLO Dernières nouvelles

Plus de nouvelles

Form S-8 - Securities to be offered to employees in employee benefit plans
Edgar (US Regulatory)
il y a 9 heures
ALLO (-8,25%)

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Edgar (US Regulatory)
il y a 9 heures
ALLO (-8,25%)

Form 8-K - Current report
Edgar (US Regulatory)
il y a 9 heures
ALLO (-8,25%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
05 Mars 2025
ALLO (-8,25%)

Form 3 - Initial statement of beneficial ownership of securities
Edgar (US Regulatory)
05 Mars 2025
ALLO (-8,25%)

Form 8-K - Current report
Edgar (US Regulatory)
25 Février 2025
ALLO (-8,25%)
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1001.92.321.8731102622.08212094CS
40.4732.86713286711.433.781.36105521622.39856198CS
12-0.02-1.041666666671.923.781.3255758152.234332CS
26-0.79-29.36802973982.693.781.3237255082.347525CS
52-2.96-60.90534979424.865.111.3230797322.60412784CS
156-6.27-76.74418604658.1717.491.3224451664.93498348CS
260-19.69-91.199629458121.59551.3219197069.85033318CS

ALLO - Frequently Asked Questions (FAQ)

What is the current Allogene Therapeutics share price?
The current share price of Allogene Therapeutics is US$ 1,90
How many Allogene Therapeutics shares are in issue?
Allogene Therapeutics has 209 672 091 shares in issue
What is the market cap of Allogene Therapeutics?
The market capitalisation of Allogene Therapeutics is USD 431,92M
What is the 1 year trading range for Allogene Therapeutics share price?
Allogene Therapeutics has traded in the range of US$ 1,32 to US$ 5,11 during the past year
What is the PE ratio of Allogene Therapeutics?
The price to earnings ratio of Allogene Therapeutics is -1,2
What is the cash to sales ratio of Allogene Therapeutics?
The cash to sales ratio of Allogene Therapeutics is 3,76k
What is the reporting currency for Allogene Therapeutics?
Allogene Therapeutics reports financial results in USD
What is the latest annual turnover for Allogene Therapeutics?
The latest annual turnover of Allogene Therapeutics is USD 95k
What is the latest annual profit for Allogene Therapeutics?
The latest annual profit of Allogene Therapeutics is USD -327,27M
What is the registered address of Allogene Therapeutics?
The registered address for Allogene Therapeutics is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the Allogene Therapeutics website address?
The website address for Allogene Therapeutics is www.allogene.com
Which industry sector does Allogene Therapeutics operate in?
Allogene Therapeutics operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
RGCRegencell Bioscience Holdings Ltd
US$ 14,25
(239,29%)
23,33M
LZMHLZ Technology Holdings Ltd
US$ 13,29
(62,47%)
860,76k
HMRHeidmar Maritime Holdings Corporation
US$ 4,08
(60,00%)
84,65M
ICONIcon Energy Corporation
US$ 0,1356
(45,65%)
85,57M
AVAHAveanna Healthcare Holdings Inc
US$ 5,15
(37,70%)
3,4M
CMCTCreative Media and Community Trust Corporation
US$ 0,35
(-46,15%)
2,1M
SPHLSpringview Holdings Ltd
US$ 0,7194
(-41,98%)
2,7M
ADTXAditxt Inc
US$ 0,0339
(-40,32%)
118,87M
ULYUrgent ly Inc
US$ 0,3086
(-39,44%)
1,76M
PSTVPlus Therapeutics Inc
US$ 0,7501
(-38,01%)
3,89M
SPGCSacks Parente Golf Inc
US$ 0,1388
(28,52%)
365,79M
NVDANVIDIA Corporation
US$ 115,58
(-0,14%)
298,57M
INTCIntel Corporation
US$ 23,70
(14,60%)
243,25M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 8,585
(-6,07%)
217,49M
TQQQProShares UltraPro QQQ
US$ 57,79
(-5,46%)
121,22M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

NASDAQ
ALLO
Allogene Therapeutics
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés

Supprimer les publicités

Inscrivez-vous pour une expérience sans publicité

Aucune publicité

Essayez maintenant

Conserver les annonces